ARCHIVES

Bristol-Myers Squibb Board Removes CEO Peter Dolan Over Plavix Deal. Two Republican Senators Say They Will Place Holds On Confirmation of Andrew von Eschenbach as FDA Commissioner. Craig Thompson Named Director of Abramson Cancer Center.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

November 1, 1985

Creating the Modern Cancer Center

November 2, 2021

Breast Cancers Detected By Mammograms Have Better Prognosis, Trials Analysis Finds

September 30, 2005

New Agents, New Approaches Benefit Treatment Of Advanced Lung Cancer

August 29, 2003

Heavy Smokers And Drinkers Have Different Brain Chemistry

May 30, 2003

Five-year Childhood ALL Survival Increased To 90.4 Percent by 2005

March 30, 2012